NVO
Novo Nordisk·NYSE
--
--(--)
--
--(--)
5.72 / 10
Netural
Analyst coverage is neutral, with two analysts rating Novo Nordisk as Neutral and mixed historical returns. Fund‑flow metrics are strong (7.7/10), showing solid inflows (~48%) despite a negative trend across all investor sizes, suggesting continued buying pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
James QuigleyNeutral
Date2026-03-02
InstitutionGoldman Sachs
Times predicted2
Historical Win Rate50.0%
Richard VosserNeutral
What is the analyst consensus for NVO?
- NVO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.72/10 (Netural).
